Empowering Breast Cancer Clients Through AI Chatbots: Transforming Knowledge and Attitudes for Enhanced Nursing Care
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 122
- 试验地点
- 1
- 主要终点
- Breast Cancer Knowledge Improvement
研究概览
简要总结
The goal of this clinical trial is to investigate the impact of an AI-powered chatbot intervention on improving knowledge, attitudes, and empowerment in breast cancer patients. The study focuses on female breast cancer patients, aged 18 years or older, who are receiving treatment at Kafr El-Sheikh University Hospital in Egypt.
The main questions it aims to answer are:
Can the AI chatbot intervention improve breast cancer knowledge compared to standard care?
Can the AI chatbot intervention positively influence attitudes toward AI in healthcare?
Does the AI chatbot intervention enhance patient empowerment in managing breast cancer?
Researchers will compare:
Intervention group (AI chatbot + standard care) to control group (standard care alone) to see if the AI chatbot intervention leads to greater improvements in knowledge, more positive attitudes towards AI, and higher perceived empowerment.
Participants will:
Engage with an AI-powered chatbot designed to provide personalized education on breast cancer, treatment options, and emotional support.
Complete pre- and post-intervention assessments to measure changes in knowledge, attitudes toward AI, and empowerment.
Receive standard care, including routine oncology consultations and nursing support, alongside the chatbot intervention (for the intervention group).
详细描述
This study explores the integration of AI-powered chatbots in breast cancer care to enhance patient education, self-management, and psychosocial support. Breast cancer is often accompanied by a range of psychological challenges, including anxiety and uncertainty about treatment options, side effects, and overall prognosis. Traditional healthcare systems struggle to provide continuous support, which is where AI technology can offer a solution by enabling 24/7 access to information and emotional support.
The study design employs a quasi-experimental approach, where 122 breast cancer patients were recruited from Kafr El-Sheikh University Hospital. Participants were randomly assigned to one of two groups:
Intervention Group (n=61): Participants in this group received standard care, which includes routine consultations with oncology specialists and nurses, in addition to an AI chatbot intervention. The chatbot delivered personalized educational content about breast cancer, treatment options, and self-care. It also offered emotional support by answering queries and providing motivational messages.
Control Group (n=61): Participants in this group received only standard care, which consisted of regular oncology consultations and nursing support without the chatbot.
The AI chatbot intervention is designed to:
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Female participants diagnosed with breast cancer, regardless of cancer stage.
- •Age 18 years or older.
- •Ability to read and communicate in Arabic to interact with the AI chatbot.
- •Willingness to participate in the study and to engage with the AI chatbot for the duration of the intervention.
- •Ability to provide informed consent.
排除标准
- •Participants with cognitive impairments or serious mental health conditions that may hinder understanding or participation in the study.
- •Patients currently receiving palliative care, as they may prioritize symptom management over educational interventions.
- •Participants who are physically unable to engage with the study's digital tools or complete assessments (e.g., due to severe illness).
- •Individuals who are unable to communicate in Arabic, as the AI chatbot intervention is designed in Arabic.
研究组 & 干预措施
Intervention Group (AI Chatbot + Standard Care)
Participants in this arm will receive standard oncology care in addition to interacting with an AI-powered chatbot. The chatbot will provide personalized educational content on breast cancer, treatment options, side effects, and offer emotional support. Participants will engage with the chatbot for 4 weeks, with assessments at baseline and post-interventi
干预措施: AI Chatbot for Breast Cancer Patient Education and Empowerment (Behavioral)
Control Group (Standard Care Only)
Participants in this arm will receive standard oncology care only, including routine consultations with oncology specialists and nurses. They will not have access to the AI chatbot intervention.
结局指标
主要结局
Breast Cancer Knowledge Improvement
时间窗: 2 months
This outcome measures the change in breast cancer knowledge from baseline to post-intervention for participants who used the AI chatbot compared to the control group. Knowledge is assessed using the Artificial Intelligence of Breast Cancer Questionnaire, which covers topics such as treatment options, side effects, symptom management, and AI's role in healthcare.
次要结局
未报告次要终点
研究者
Mostafa Shaban
Dr
Cairo University